Every round on record, with the sources behind each and the investors on them.
The AI drug discovery unit spun out of ByteDance
anewbt.comShanghaiAI
4 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Valuation none read as $1.5B (thenextweb.com)
Sources agree. The article states Anew Labs has operations in Shanghai, Singapore, and San Jose, California, but does not state headquarters.; not on the page it cites, so not applied: date
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $290M $290M in disclosed external funding financing total | 2026-09-16 | 5Y Capital, Hillhouse, HSG, IDG Capital | No recent discussion |
4 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 4 sources
Valuation none read as $1.5B (thenextweb.com) Sources agree. The article states Anew Labs has operations in Shanghai, Singapore, and San Jose, California, but does not state headquarters.; not on the page it cites, so not applied: date [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]4 pages read: techstartups.com, thenextweb.com, digitimes.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 4 sources·[ AGENT ]company research by the Firecrawl agent | ||||
Anew Labs builds AI-powered drug-discovery tools and combines them with experimental science to create new medicines for patients.
Checked against 10 sources today
Also named as backers in company research: ByteDance, GL Ventures